Posted on September 4th, 20209/4/20
Innovative rare disease therapies deserve innovative value and access strategies. With over 1,500 attendees from 50+ countries, the World Orphan Drug Congress featured four days of education, conversation and brainstorming dedicated to drug development and commercialization. EVERSANA’s CEO, Jim Lang, had the esteemed honor of hosting Pfizer’s Vice President of Rare Disease, Patient & Health […]
Posted on August 31st, 20208/31/20
In his latest white paper, Oodaye Shukla, EVERSANA’s Chief Data and Analytics Officer, outlines the revolutionary impact that artificial intelligence and machine learning can have on improving patient outcomes and access to therapy. Rare disease statistics: The average time to get an accurate rare diagnosis is 6-8 years. There are 7,000 distinct types of rare […]
Posted on July 13th, 20207/13/20
An emerging clinical stage biotech contracted with EVERSANA to conduct Phase II trial enrollment support for an ultra-rare liver disease through our Seeker Health platform. Because of the ultra-rare patient population and nature of the therapy, the client expected significant recruitment challenges. Read more, download the full case study: Learn more about Seeker Health® by […]
Posted on July 9th, 20207/9/20
As the patient point of care continues to change and evolve, EVERSANA has identified challenges facing how we interact with patients, and how these challenges will impact patient engagement now and in the future. Supporting patients and providing them with valuable information is key. Our Seeker Health Team has introduced and personalized multi-channel outreach campaigns […]
Posted on June 15th, 20206/15/20
As the public health pandemic spreads, EVERSANA has identified challenges facing clinical trial participation, and how these challenges will impact patients now and following the COVID-19 pandemic. […] Supporting patients and providing them with valuable information is key. Our Seeker Health Team has introduced and personalized multi-channel outreach campaigns to inform patients of relevant updates, […]
Posted on March 13th, 20203/13/20
[Webinar: 23 Minutes] With over 20 years experience on the clinical research arena, Mike Ryan shares the importance of patient engagement from the clinical trial all the way across the drug development continuum. He highlights that although some patients might not qualify for the clinical trial, they should continue to be relevant as future clients/patients […]
Posted on January 20th, 20201/20/20
Commercial Strategies for a Successful Product Launch. With the launch of new blockbuster drugs becoming less frequent, there is increased scrutiny on the importance and success of clinical trials, mandatory to determining the safety and efficacy of a developing product. The road to commercialization is daunting – the process of bringing a product to market […]
